GOLDMAN SACHS GROUP INC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$464,000
-9.9%
1,137,955
-17.3%
0.00%
Q3 2016$515,000
+1.6%
1,375,394
-7.7%
0.00%
Q2 2016$507,000
+692.2%
1,490,528
+1137.2%
0.00%
Q1 2016$64,000
-83.9%
120,480
-62.8%
0.00%
Q4 2015$398,000
+0.5%
323,509
+19.1%
0.00%
Q3 2015$396,000
-59.6%
271,582
-45.9%
0.00%
Q2 2015$979,000
+53.4%
502,188
+42.4%
0.00%
Q1 2015$638,000
-54.0%
352,700
-39.9%
0.00%
Q4 2014$1,386,000
+26.6%
587,078
+29.7%
0.00%
Q3 2014$1,095,000
-3.1%
452,470
+12.5%
0.00%
Q2 2014$1,130,000402,0510.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2015
NameSharesValueWeighting ↓
EAGLE ASSET MANAGEMENT INC 15,707,022$38,010,0000.11%
First Heartland Consultants, Inc. 74,624$181,0000.08%
WASHINGTON TRUST Co 410,616$994,0000.07%
Geduld E E 40,000$97,0000.07%
FIRST NEW YORK SECURITIES LLC /NY 30,562$73,960,0000.05%
Crosspoint Capital Strategies, LLC 25,000$61,0000.04%
JANE STREET GROUP, LLC 1,434,975$3,473,0000.04%
MAGEE THOMSON INVESTMENT PARTNERS LLC 21,479$51,0000.01%
TIAA CREF TRUST CO FSB/MO 296,322$717,0000.01%
Investors Capital Advisory Services 16,950$41,0000.01%
View complete list of CTI BIOPHARMA CORP shareholders